Skip to main content

Kintegral Advisory, LLC

Position in PFE — Pfizer Inc

CIK 1569518 New York, NY

Position in PFE

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$3,867,055
-$642,368 QoQ
Shares Held
160,592
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#706
of 2,826 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in PFE Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Kintegral Advisory, LLC holds $82,893,440 across 8 Drug Manufacturers - General names. PFE ranks #8 (4.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 PFE
Pfizer Inc
This page
160,592 $3,867,055

All Filings in PFE

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,867,055 160,592
2026-03-31 $4,509,423 160,592
2025-12-31 $4,176,053 167,713
2025-09-30 $4,390,280 172,303
2025-06-30 $4,195,313 173,074
2025-03-31 $4,392,308 173,335
2024-12-31 $4,614,018 173,917
2024-09-30 $5,267,629 182,019
2024-06-30 $5,159,623 184,404
2024-03-31 $1,492,894 53,798
2023-12-31 $1,553,681 53,966
2023-09-30 $1,801,462 54,310
2023-06-30 $1,993,264 54,342
2023-03-31 $2,217,153 54,342
2022-12-31 $2,934,053 57,261
2022-09-30 $2,914,941 66,612
2022-06-30 $3,492,467 66,612
2022-03-31 $3,375,455 65,201
2021-12-31 $3,763,965 63,742
2021-09-30 $2,741,543 63,742
2021-06-30 $2,496,136 63,742
2021-03-31 $2,309,372 63,742
2020-12-31 $2,346,343 63,742
2020-09-30 $2,339,329 63,742
2020-06-30 $2,151,466 65,794
2020-03-31 $2,147,513 65,794